Literature DB >> 34313294

A lipidomic view of SARS-CoV-2.

Kourosh H Ebrahimi1, James S O McCullagh1.   

Abstract

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic approaches. New data suggest that lipid metabolism may play a significant role in regulating the response of immune cells like macrophages to viral infection, thereby affecting the outcome of the disease. Therefore, understanding the role of lipid metabolism could help develop new therapeutic approaches to mitigate the social and economic cost of coronavirus disease 2019 (COVID-19).
© 2021 The Author(s).

Entities:  

Keywords:  COVID-19; HDL; Immune system; Metabolomics; SARS-CoV-2; lipids

Year:  2021        PMID: 34313294     DOI: 10.1042/BSR20210953

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  4 in total

1.  Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy).

Authors:  Michele Ciccarelli; Fabrizio Merciai; Albino Carrizzo; Eduardo Sommella; Paola Di Pietro; Vicky Caponigro; Emanuela Salviati; Simona Musella; Veronica di Sarno; Mariarosaria Rusciano; Anna Laura Toni; Paola Iesu; Carmine Izzo; Gabriella Schettino; Valeria Conti; Eleonora Venturini; Carolina Vitale; Giuliana Scarpati; Domenico Bonadies; Antonella Rispoli; Benedetto Polverino; Sergio Poto; Pasquale Pagliano; Ornella Piazza; Danilo Licastro; Carmine Vecchione; Pietro Campiglia
Journal:  J Pharm Biomed Anal       Date:  2022-05-10       Impact factor: 3.571

Review 2.  COVID-19 metabolism: Mechanisms and therapeutic targets.

Authors:  Tianshi Wang; Ying Cao; Haiyan Zhang; Zihao Wang; Cheuk Him Man; Yunfan Yang; Lingchao Chen; Shuangnian Xu; Xiaojing Yan; Quan Zheng; Yi-Ping Wang
Journal:  MedComm (2020)       Date:  2022-08-09

Review 3.  Enzymes in the time of COVID-19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs.

Authors:  Luana Xavier Soares Gomes Moura Fé; Eliane Pereira Cipolatti; Martina Costa Cerqueira Pinto; Suema Branco; Fábio César Sousa Nogueira; Gisela Maria Dellamora Ortiz; Anderson de Sá Pinheiro; Evelin Andrade Manoel
Journal:  Med Res Rev       Date:  2022-06-28       Impact factor: 12.388

4.  Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.

Authors:  Céline Occelli; Jean-Marie Guigonis; Sabine Lindenthal; Alexandre Cagnard; Fanny Graslin; Vesna Brglez; Barbara Seitz-Polski; Jean Dellamonica; Jacques Levraut; Thierry Pourcher
Journal:  Front Med (Lausanne)       Date:  2022-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.